TWT / TRY

TWT / USDT

FTT / USDT

BEAMX / TRY

OMNI / USDC

OMNI / TRY

OMNI / USDT

OMNI / BTC

OMNI / FDUSD

BEAMX / USDT

RVN / BTC

HOLO / BNB

HOLO / USDT

HOLO / USDC

HOLO / TRY

BIO / BNB

HOLO / FDUSD

DOLO / USDC

DOLO / USDT

DOLO / BNB

CAREER POINT EDUTECH LTD

NATURAL CAPSULES LIMITED

TRIGYN TECHNOLOGIES LTD

INTENSE TECHNOLOGIES LTD

SNEHAA ORGANICS LIMITED

RAPPID VALVES (INDIA) LTD

BHARAT GEARS LTD.

ARO GRANITE IND. LTD.

EXICOM TELE SYSTEMS LTD

INTRASOFT TECH. LTD

TOURISM FINANCE CORP. OF

SARVESHWAR FOODS LIMITED

TWAMEV CONS AND INFRA LTD

BAWEJA STUDIOS LIMITED

ALPS INDUSTRIES LTD.

MT EDUCARE LTD

NDR AUTO COMPONENTS LTD

HINDUSTAN MOTORS LIMITED

OSIA HYPER RETAIL LIMITED

S.A.L. STEEL LTD.

Click here to get full coverage on DIVIS LABORATORIES LTD. (DIVISLAB.BO) Q1 24/25 earnings call transcript - Yahoo Finance

DIVIS LABORATORIES LTD. (DIVISLAB.BO) Q1 24/25 earnings call transcript  Yahoo Finance

DIVIS LABORATORIES LTD. (DIVISLAB.BO) Q1 24/25 earnings call transcript - Yahoo Finance

Click here to get full coverage on Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days - simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days  simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days - simplywall.st

Click here to get full coverage on Divis Laboratories shares rise 2.12% in early trade - TradingView

Divis Laboratories shares rise 2.12% in early trade  TradingView

Divis Laboratories shares rise 2.12% in early trade - TradingView

Click here to get full coverage on Divi’s Laboratories Announces Trading Window Closure - TipRanks

Divi’s Laboratories Announces Trading Window Closure  TipRanks

Divi’s Laboratories Announces Trading Window Closure - TipRanks

Click here to get full coverage on Divi's Laboratories Limited's (NSE:DIVISLAB) Share Price Could Signal Some Risk - simplywall.st

Divi's Laboratories Limited's (NSE:DIVISLAB) Share Price Could Signal Some Risk  simplywall.st

Divi's Laboratories Limited's (NSE:DIVISLAB) Share Price Could Signal Some Risk - simplywall.st

Click here to get full coverage on Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr  Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Click here to get full coverage on Divi s Laboratories Limited (DIVISLAB) Sees Unusual Trading Volume - Exceptional trading results - AutoCar Pro

Divi s Laboratories Limited (DIVISLAB) Sees Unusual Trading Volume - Exceptional trading results  AutoCar Pro

Divi s Laboratories Limited (DIVISLAB) Sees Unusual Trading Volume - Exceptional trading results - AutoCar Pro

Click here to get full coverage on India's Divi's Lab jumps on supply agreement, tops pharma index - TradingView

India's Divi's Lab jumps on supply agreement, tops pharma index  TradingView

India's Divi's Lab jumps on supply agreement, tops pharma index - TradingView

Click here to get full coverage on Divi’s Laboratories Reports Stable Q1 Financial Results for 2025 - TipRanks

Divi’s Laboratories Reports Stable Q1 Financial Results for 2025  TipRanks

Divi’s Laboratories Reports Stable Q1 Financial Results for 2025 - TipRanks

Click here to get full coverage on Divi's Laboratories Limited's (NSE:DIVISLAB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st

Divi's Laboratories Limited's (NSE:DIVISLAB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?  simplywall.st

Divi's Laboratories Limited's (NSE:DIVISLAB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st

Click here to get full coverage on Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share  Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Click here to get full coverage on Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher - TradingView

Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher  TradingView

Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher - TradingView

Click here to get full coverage on Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript - TipRanks

Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript  TipRanks

Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript - TipRanks

Click here to get full coverage on Divi's Laboratories (NSE:DIVISLAB) jumps 5.4% this week, though earnings growth is still tracking behind five-year shareholder returns - simplywall.st

Divi's Laboratories (NSE:DIVISLAB) jumps 5.4% this week, though earnings growth is still tracking behind five-year shareholder returns  simplywall.st

Divi's Laboratories (NSE:DIVISLAB) jumps 5.4% this week, though earnings growth is still tracking behind five-year shareholder returns - simplywall.st

Click here to get full coverage on India's Divi's Labs gains as Citi hikes PT citing weight-loss drugs' prospects - TradingView

India's Divi's Labs gains as Citi hikes PT citing weight-loss drugs' prospects  TradingView

India's Divi's Labs gains as Citi hikes PT citing weight-loss drugs' prospects - TradingView

Click here to get full coverage on Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation  simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Click here to get full coverage on Divis Laboratories shares rise 2.11%, among top gainers on Nifty Next 50 - TradingView

Divis Laboratories shares rise 2.11%, among top gainers on Nifty Next 50  TradingView

Divis Laboratories shares rise 2.11%, among top gainers on Nifty Next 50 - TradingView

Click here to get full coverage on Divi's Laboratories Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st

Divi's Laboratories Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now  simplywall.st

Divi's Laboratories Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st

Click here to get full coverage on Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy - simplywall.st

Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy  simplywall.st

Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy - simplywall.st

Click here to get full coverage on With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently  simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

Click here to get full coverage on Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings - CNBC TV18

Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings  CNBC TV18

Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings - CNBC TV18

Click here to get full coverage on Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict  Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Click here to get full coverage on Divis Lab spurts as broker maintains buy call - Business Standard

Divis Lab spurts as broker maintains buy call  Business Standard

Divis Lab spurts as broker maintains buy call - Business Standard

Click here to get full coverage on Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.  Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Click here to get full coverage on Divis Labs bucks weak pharma shares trend; hits new high on strong Q1 hopes - Business Standard

Divis Labs bucks weak pharma shares trend; hits new high on strong Q1 hopes  Business Standard

Divis Labs bucks weak pharma shares trend; hits new high on strong Q1 hopes - Business Standard

Click here to get full coverage on Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages Radar - NDTV Profit

Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages Radar  NDTV Profit

Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages Radar - NDTV Profit

Click here to get full coverage on Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest? - The Economic Times

Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest?  The Economic Times

Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest? - The Economic Times

Click here to get full coverage on Divi's Laboratories Q1 Results: Stock falls after profit, margins miss estimates - CNBC TV18

Divi's Laboratories Q1 Results: Stock falls after profit, margins miss estimates  CNBC TV18

Divi's Laboratories Q1 Results: Stock falls after profit, margins miss estimates - CNBC TV18

Click here to get full coverage on Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB  Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Click here to get full coverage on NSE DIVISLAB – Will Price Hit the Final Target? - Moneymunch

NSE DIVISLAB – Will Price Hit the Final Target?  Moneymunch

NSE DIVISLAB – Will Price Hit the Final Target? - Moneymunch

Click here to get full coverage on Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend  CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Click here to get full coverage on Divis Laboratories Inks Supply Pact With Global Pharmaceutical Entity - NDTV Profit

Divis Laboratories Inks Supply Pact With Global Pharmaceutical Entity  NDTV Profit

Divis Laboratories Inks Supply Pact With Global Pharmaceutical Entity - NDTV Profit

Click here to get full coverage on Divi's Lab stock slips on US supply worries - The Economic Times

Divi's Lab stock slips on US supply worries  The Economic Times

Divi's Lab stock slips on US supply worries - The Economic Times

Click here to get full coverage on Divi s Laboratories Limited (DIVISLAB) to Launch New Product Line - Fastest-growing stock picks - AutoCar Pro

Divi s Laboratories Limited (DIVISLAB) to Launch New Product Line - Fastest-growing stock picks  AutoCar Pro

Divi s Laboratories Limited (DIVISLAB) to Launch New Product Line - Fastest-growing stock picks - AutoCar Pro

Click here to get full coverage on Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25%  The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Click here to get full coverage on Divis Laboratories Q2 Results: Profit Jumps 47%, Beats Estimates - NDTV Profit

Divis Laboratories Q2 Results: Profit Jumps 47%, Beats Estimates  NDTV Profit

Divis Laboratories Q2 Results: Profit Jumps 47%, Beats Estimates - NDTV Profit

Click here to get full coverage on NSE ONGC, DIVISLAB & UPL – Trading Insight - Moneymunch

NSE ONGC, DIVISLAB & UPL – Trading Insight  Moneymunch

NSE ONGC, DIVISLAB & UPL – Trading Insight - Moneymunch

Click here to get full coverage on Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors?  Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Click here to get full coverage on Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - Moneycontrol

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?  Moneycontrol

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - Moneycontrol

Click here to get full coverage on Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?  The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Click here to get full coverage on Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - HDFC Sky

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr  HDFC Sky

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - HDFC Sky

Click here to get full coverage on Top stock recommendations for January 21, 2025 - Times of India

Top stock recommendations for January 21, 2025  Times of India

Top stock recommendations for January 21, 2025 - Times of India

Click here to get full coverage on Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target - Moneycontrol

Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target  Moneycontrol

Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target - Moneycontrol

Click here to get full coverage on Anil Singhvis Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Anil Singhvis Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside  Zee Business

Anil Singhvis Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Click here to get full coverage on Divis Laboratories Q2 results: Profit and EBITDA jump over 45% beating Street estimates - CNBC TV18

Divis Laboratories Q2 results: Profit and EBITDA jump over 45% beating Street estimates  CNBC TV18

Divis Laboratories Q2 results: Profit and EBITDA jump over 45% beating Street estimates - CNBC TV18

Click here to get full coverage on Divi's Labs: Strong Q3, growth outlook positive, valuation debate continues - Business Standard

Divi's Labs: Strong Q3, growth outlook positive, valuation debate continues  Business Standard

Divi's Labs: Strong Q3, growth outlook positive, valuation debate continues - Business Standard

Click here to get full coverage on Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR - Business Standard

Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR  Business Standard

Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR - Business Standard

Click here to get full coverage on Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target - CNBC TV18

Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target  CNBC TV18

Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target - CNBC TV18

Click here to get full coverage on Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25% - Upstox

Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25%  Upstox

Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25% - Upstox

Click here to get full coverage on Here’s why Divi’s Laboratories stock faced pressure on Tuesday - CNBC TV18

Here’s why Divi’s Laboratories stock faced pressure on Tuesday  CNBC TV18

Here’s why Divi’s Laboratories stock faced pressure on Tuesday - CNBC TV18

Click here to get full coverage on Divi's Labs Q2 Results: Net profit rises 46% to Rs 510 crore, revenue at Rs 2,338 crore - Moneycontrol

Divi's Labs Q2 Results: Net profit rises 46% to Rs 510 crore, revenue at Rs 2,338 crore  Moneycontrol

Divi's Labs Q2 Results: Net profit rises 46% to Rs 510 crore, revenue at Rs 2,338 crore - Moneycontrol

Click here to get full coverage on Divis Laboratories shares decline 3.12% amid volume surge; stock among top losers on Nifty Next 50 - TradingView

Divis Laboratories shares decline 3.12% amid volume surge; stock among top losers on Nifty Next 50  TradingView

Divis Laboratories shares decline 3.12% amid volume surge; stock among top losers on Nifty Next 50 - TradingView

Click here to get full coverage on What Next for Divi's Lab and LTIMindtree After Nifty Rejig? - Equitymaster

What Next for Divi's Lab and LTIMindtree After Nifty Rejig?  Equitymaster

What Next for Divi's Lab and LTIMindtree After Nifty Rejig? - Equitymaster

Click here to get full coverage on Divi's Lab share price: Why experts are bullish on this pharma stock? - Mint

Divi's Lab share price: Why experts are bullish on this pharma stock?  Mint

Divi's Laboratories Limited (DIVISLAB)

Price Chart

Key Statistics

Technicals

About DIVISLAB

Latest News

DIVIS LABORATORIES LTD. (DIVISLAB.BO) Q1 24/25 earnings call transcript - Yahoo Finance

Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days - simplywall.st

Divis Laboratories shares rise 2.12% in early trade - TradingView

Advanced Charts

Top Gainers

Top Losers